IL17A and endometrial cancer: However, in a study by Lu et al., mRNA expression of pro-inflammatory cytokines (e.g., IL-6, IL-8, and IL-17) was found to be significantly increased in endometrial cancer women when compared to benign uterine lesion cohort [31].